Long-term safety and disease control with Ruxolitinib cream in atopic dermatitis: Pooled results from two phase 3 studies

被引：0
|
作者：
Papp, K. [1 ]
Szepietowski, J. C. [2 ]
Kircik, L. [3 ]
Toth, D. [4 ]
Eichenfield, L. F. [5 ,6 ]
Forman, S. B. [7 ]
Kuligowski, M. E. [8 ]
Venturanza, M. E. [8 ]
Ren, H. [8 ]
Simpson, E. L. [9 ]
机构：
[1] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[2] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
[5] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA
[7] ForCare Clin Res, Tampa, FL USA
[8] Incyte Corp, Wilmington, NC USA
[9] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
94
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: pooled results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Ren, H.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E167 - E167
  • [2] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Kuligowski, Michael E.
    Kallender, Howard
    Sun, Kang
    Ren, Haobo
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1008 - 1016
  • [3] Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
    Papp, K.
    Szepietowski, J.
    Kircik, L.
    Toth, D.
    Eichenfield, L.
    Forman, S.
    Kuligowski, M.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S184 - S184
  • [4] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E134 - E135
  • [5] Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Papp, Kim
    Szepietowski, Jacek C.
    Blauvelt, Andrew
    Kircik, Leon
    Silverberg, Jonathan I.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Kallender, Howard
    Ren, Haobo
    Paller, Amy S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (04) : 669 - 683
  • [6] Long-term safety and disease control with ruxolitinib cream in patients with more severe atopic dermatitis: pooled results from two phase III studies
    Simpson, E. L.
    Kircik, L.
    Blauvelt, A.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Eichenfield, L. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E135 - E136
  • [7] Long-term safety and disease control with ruxolitinib cream in patients with atopic dermatitis based on previous medication history: pooled results from two phase III studies
    Blauvelt, A.
    Eichenfield, L. F.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E136 - E137
  • [8] Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Ren, Haobo
    Brar, Kanwaljit K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB180 - AB180
  • [9] Response to Papp et al's "Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies"
    Isaq, Nasro A.
    Link, Jenny L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : e19 - e20
  • [10] Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB158 - AB158
12345